Ein von ISO 9001, 14001, 45001 zertifiziertes Unternehmen sales@bldpharm.com
Währung :
Sprache : Deutsch |
Standort :
Standort
  • Americas
    • Europe
      • Asia Pacific
        • Africa & Middle East
          |
          Startseite/ Chemistry/ Asymmetric Synthesis/ Chiral Building Blocks/(3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

          (3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

          CAS NO.: 2140-46-7  
            Größe Preis Verkaufsrabatt Rabatt Lager-CN Lager-US Lager-IND Lager-EU Menge
            How to Order

            The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

            How to Order

            QUALITÄTSKONTROLLE Batch NO.:

            PRODUKT INFORMATION

            Produkt Name : (3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
            CAS Nr. : 2140-46-7 Molekulargewicht : 402.65
            MDL Nr. : MFCD00057815 Feinheit/Spezifikation :
            Molekularformel : C27H46O2 Lagerung : Sealed in dry,Room Temperature
            Siedepunkt : No data available
            GHS Pictogram :
            Signal Word : Warning Precautionary Statements : P261-P280-P305+P351+P338
            UN# : - Class : -
            Hazard Statements : H302-H312-H315-H319-H332-H335-H373 Packing Group : -

            ZUSAMMENHÄNGENDE PRODUKTE

            HISTORISCHE AUFZEICHNUNGEN